The YBP2 antibody targets the Y-box-binding protein 2 (YBX2), also known as MSY2 or Contrin, a nucleic acid-binding protein critical for mRNA stability, translational regulation, and germ cell development . It is a recombinant monoclonal antibody (clone EPR2814(2), ab154829) developed for research applications, offering high specificity and reproducibility .
Recombinant production ensures batch-to-batch consistency and animal-free formulation .
Targets a synthetic peptide corresponding to residues in human YBX2 (UniProt: Q9Y2T7) .
| Feature | Details |
|---|---|
| Host Species | Rabbit |
| Clonality | Monoclonal (Recombinant) |
| Recommended Dilution | WB: 1/1000; ICC/IF: 1/50 |
| Positive Controls | Human seminoma, mouse/rat testis lysates, HepG2 cells |
YBX2 is a major component of messenger ribonucleoprotein particles (mRNPs) and regulates mRNA stability and translation, particularly in germ cells . It binds mRNA in a sequence-independent manner and plays roles in cytoplasmic mRNA storage and translational delay .
Chromosome Segregation: In Saccharomyces cerevisiae, Ybp2 associates with the central kinetochore, interacting with COMA and Ndc80 complexes to ensure proper mitotic progression .
Checkpoint Dependence: The G2/M arrest caused by ybp2Δ mutants is Mad2-dependent, linking Ybp2 to spindle checkpoint signaling .
Ybp2 co-immunoprecipitates with kinetochore proteins (Ctf19, Ndc80, Cse4) and associates with centromeric DNA .
Chromatin immunoprecipitation (ChIP) confirmed Ybp2’s specific binding to CEN DNA, dependent on Ndc10 .
ybp2Δ mutants exhibit benomyl sensitivity and G2/M arrest, indicating defective chromosome segregation .
Synthetic lethality with mad2Δ highlights functional overlap in checkpoint pathways .
Cancer: YBX2 overexpression is linked to tumor progression, making it a potential therapeutic target .
Infertility: YBX2’s role in germ cell mRNA regulation suggests implications for reproductive disorders .
KO Cell Line Validation: Superior performance in knockout controls for WB and ICC/IF .
Vendor Collaboration: 20% of tested antibodies failing validation were removed from commercial catalogs .
Multiparatopic Antibodies: Engineering biparatopic formats (e.g., targeting multiple epitopes) could enhance therapeutic efficacy against evolving targets like viral variants or tumor antigens .
High-Throughput Screening: Scalable validation protocols (e.g., YCharOS initiatives) aim to improve antibody reliability across the proteome .
KEGG: sce:YGL060W
STRING: 4932.YGL060W
YBP2 is a protein that was identified in Saccharomyces cerevisiae through a synthetic genetic array (SGA) screen using a mad2-deletion strain. It shares sequence similarity with YBP1, which is required for H₂O₂-induced oxidation of the transcription factor Yap1 . Antibodies against YBP2 are crucial research tools because they allow for the detection, localization, and functional analysis of YBP2 in cellular contexts. These antibodies have been instrumental in demonstrating that YBP2 physically associates with proteins of the COMA complex and components of the Ndc80 complex in the central kinetochore, as well as with Cse4, the centromeric histone and CENP-A homolog . Without specific antibodies, many of the co-immunoprecipitation studies that have revealed YBP2's role in kinetochore function would not have been possible.
YBP2 antibodies enable multiple experimental approaches for investigating kinetochore assembly and function. They can be used for:
Immunoprecipitation (IP) assays to identify protein-protein interactions, as demonstrated in studies showing YBP2's association with kinetochore complexes
Chromatin immunoprecipitation (ChIP) assays to verify centromeric DNA association, which has confirmed that YBP2 specifically associates with CEN DNA in vivo
Western blotting to assess protein expression levels and post-translational modifications
Immunofluorescence microscopy to determine subcellular localization during different cell cycle phases
Flow cytometry to analyze cell cycle profiles in wild-type versus mutant cells
These applications collectively provide a comprehensive toolkit for investigating the molecular function of YBP2 in chromosome segregation and kinetochore assembly.
YBP2 exhibits a specific interaction pattern within the kinetochore architecture. Based on co-immunoprecipitation studies, YBP2 interacts with:
All components of the COMA complex (Ctf19, Okp1, Mcm21, and Ame1)
Three of four components of the Ndc80 complex (Ndc80, Nuf2, and Spc25, but not Spc24)
One of four components of the MIND complex (Nsl1, but not Mtw1, Nnf1, or Dsn1)
Additional kinetochore proteins Ctf3, Mcm16, Mcm22, Chl4, and Spc105
The centromeric histone H3 variant Cse4 (yeast CENP-A homolog)
ChIP assays have confirmed YBP2's specific association with centromeric DNA, which depends on the presence of functional Ndc10 (a component of the CBF3 complex) . This suggests YBP2 may serve as a bridging molecule between the COMA and Ndc80 complexes, potentially facilitating the assembly of the central kinetochore onto centromeric nucleosomes.
YBP2 antibodies provide powerful tools for dissecting the molecular mechanisms of chromosome missegregation. Researchers can employ these antibodies in multi-faceted experimental approaches:
ChIP-sequencing with YBP2 antibodies can map genome-wide binding profiles at centromeres and potentially identify any ectopic binding sites that may contribute to chromosome instability
Combined immunoprecipitation and mass spectrometry can identify novel YBP2 interaction partners under various cellular stresses
Proximity-based labeling methods (BioID or APEX) coupled with YBP2 antibodies can reveal the dynamic protein neighborhood of YBP2 during different cell cycle phases
Quantitative immunofluorescence can measure YBP2 recruitment to kinetochores in various mutant backgrounds (e.g., ndc10-1, cse4 mutants) to establish dependency relationships
Super-resolution microscopy with YBP2 antibodies can determine the precise nanoscale organization of YBP2 within the kinetochore structure
These approaches collectively help elucidate how YBP2 dysfunction contributes to chromosome missegregation, particularly in the context of spindle checkpoint mutants where the ybp2Δ mad2Δ double mutant exhibits enhanced chromosome loss (42% compared to 1% in ybp2Δ alone) .
When investigating YBP2's relationship to the spindle checkpoint, researchers should consider several experimental design factors:
Genetic background selection: Since ybp2Δ mad2Δ double mutants show temperature-sensitive growth defects at 37°C but not at 30°C, temperature control is crucial for phenotype manifestation
Assay sensitivity: While direct synthetic lethality is not observed between ybp2Δ and mad2Δ, more sensitive assays like chromosome fragment loss assays reveal significant synthetic interactions (42% loss in the double mutant vs. 1% in ybp2Δ alone)
Multiple checkpoint component testing: Interactions should be tested with multiple spindle checkpoint components (mad1Δ, bub1Δ, etc.) to distinguish specific from general checkpoint interactions
Cell cycle synchronization: Since YBP2 functions may be cell cycle-dependent, synchronization protocols are essential for temporal resolution of its activities
Antibody specificity validation: Cross-reactivity testing against related proteins (especially YBP1) is necessary due to sequence similarity
Understanding these considerations enables properly controlled experiments that can accurately determine whether YBP2 functions within or parallel to the spindle checkpoint pathway.
Research on YBP2 has utilized both anti-YBP2 antibodies and antibodies against epitope tags (e.g., myc-tagged YBP2) . Reconciling these approaches requires:
Validation of functionality: Confirm that epitope-tagged YBP2 complements ybp2Δ phenotypes, particularly under stress conditions like benomyl treatment or elevated temperature
Comparative immunoprecipitation: Perform parallel IP experiments with native and tagged constructs to ensure consistent interaction profiles
Quantitative binding analysis: Compare ChIP signal strengths between native antibody and tag antibody approaches to ensure equivalent chromatin association
Structural considerations: Assess whether tag placement (N- versus C-terminal) affects protein interactions, especially given YBP2's proposed bridging function between kinetochore complexes
Control for tag-specific artifacts: Include appropriate tagged control proteins to identify any non-specific interactions caused by the epitope tag itself
For successful ChIP experiments using YBP2 antibodies, researchers should consider the following methodological details:
Crosslinking optimization: For YBP2 ChIP, formaldehyde crosslinking (1% for 10-15 minutes) has been successfully employed to capture interactions with centromeric DNA
Sonication parameters: Chromatin should be sheared to 200-500bp fragments, with optimization to ensure centromeric regions are adequately represented
Antibody selection: For native YBP2, purified polyclonal antibodies raised against recombinant YBP2 have shown specificity; for tagged versions, high-affinity anti-tag antibodies conjugated to magnetic beads provide efficient precipitation
Controls: Include:
PCR primer design: PCR primers specific to centromeric regions of multiple chromosomes (e.g., CEN I and CEN XVI) alongside non-centromeric control regions (e.g., PGK1) are essential for demonstrating specificity
Adherence to these methodological considerations ensures robust and reproducible ChIP results when studying YBP2's centromeric association.
When facing inconsistent co-immunoprecipitation results with YBP2 antibodies, researchers should systematically address:
Buffer composition: YBP2's interactions with COMA and Ndc80 complexes may be salt-sensitive; test multiple extraction conditions:
Low stringency: 100-150mM NaCl, 0.1% NP-40
Medium stringency: 250mM NaCl, 0.5% NP-40
High stringency: 300-500mM NaCl, 1% NP-40
Cell cycle dependence: YBP2 interactions may vary throughout the cell cycle; synchronize cells or perform time-course experiments after release from arrest
Antibody optimization:
For direct YBP2 IP: Optimize antibody concentration and pre-clear lysates to reduce background
For reverse IP (detecting YBP2 in complex): Ensure efficient precipitation of primary target proteins
Sample preparation: Test multiple extraction methods:
Native extraction using non-denaturing detergents
Crosslinked samples (using formaldehyde or DSP)
Enzymatic digestion of chromatin to release kinetochore complexes
Detection methods: When YBP2 signal is weak, consider:
Using higher sensitivity western blot substrates
Implementing a two-step IP protocol to enrich for complexes
Employing mass spectrometry for improved detection
These troubleshooting approaches help resolve technical variability and establish reproducible co-immunoprecipitation protocols for studying YBP2 interactions.
When developing or selecting YBP2 antibodies, researchers should consider:
Epitope selection: Target regions of YBP2 that are:
Unique compared to homologous proteins (especially YBP1)
Surface-exposed based on structural predictions
Not involved in critical protein-protein interactions if native interactions need to be preserved
Antibody format: Choose based on application needs:
Polyclonal antibodies: Better for detecting native protein in varied contexts
Monoclonal antibodies: Superior for specific epitopes and reproducibility
Recombinant antibodies: Offer consistency across production batches
Validation requirements:
Species compatibility: Consider:
Post-translational modification (PTM) sensitivity: Determine if:
Antibodies should recognize YBP2 regardless of PTM status
Specific modification-state antibodies are needed to study regulation
Careful consideration of these factors ensures selection of appropriate YBP2 antibodies that will generate reliable results across experimental applications.
YBP2 antibody-based research has significantly contributed to our understanding of kinetochore architecture and assembly. Current evidence positions YBP2 as a potential bridging component between the COMA and Ndc80 complexes within the central kinetochore . This model is supported by:
Co-immunoprecipitation data showing YBP2 interacts with all COMA components and three of four Ndc80 complex components
ChIP analysis confirming YBP2's specific association with centromeric DNA
Genetic interaction data revealing synthetic fitness defects between ybp2Δ and spindle checkpoint mutants
The interaction between YBP2 and Cse4, suggesting a connection to centromeric nucleosomes
These findings collectively support a model where YBP2 helps organize the three-dimensional architecture of the kinetochore, potentially forming part of the interface between inner and outer kinetochore structures. Future antibody-based studies using advanced approaches such as proximity labeling, super-resolution microscopy, and cryo-electron microscopy will further refine this model and potentially identify additional functions of YBP2 in kinetochore assembly and dynamics.